<!doctype html>
<html class="no-js" lang="en">

<head>
  <!-- Global site tag (gtag.js) - Google Analytics -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-FEDBM7F51Q"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());

    gtag('config', 'G-FEDBM7F51Q');
  </script>

  <meta charset="utf-8">
  <meta http-equiv="x-ua-compatible" content="ie=edge">
  <title>üëß ‚õ∏Ô∏è ‚ò∏Ô∏è Interview with Gary Hudson about the new anti-aging biotechnology üë©‚Äçüíª üë©üèæ‚Äç‚öïÔ∏è üíë</title>
  <link rel="icon" type="image/x-icon" href="/favicon.ico" />
  <meta name="description" content="For the last couple of years, we have seen rapid progress in various areas in the fight against sensate cells . Recently, UNITY Biotechnology made a l...">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <link rel="sitemap" type="application/xml" href="/sitemap.xml"/>

  <link rel="stylesheet" href="../../css/main.css">

  <link href="https://fonts.googleapis.com/css?family=Quicksand&display=swap" rel="stylesheet">

  <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script>

  <script>document.write('<script src="https://pagea' + 'd2.googles' + 'yndication.com/pagea' + 'd/js/a' + 'dsby' + 'google.js"><\/script>')</script>
  <script>
        var superSpecialObject = {};
        superSpecialObject['google_a' + 'd_client'] = 'ca-p' + 'ub-6974184241884155';
        superSpecialObject['enable_page_level_a' + 'ds'] = true;
       (window['a' + 'dsbygoogle'] = window['a' + 'dsbygoogle'] || []).push(superSpecialObject);
  </script>
</head>

<body>
  <!--[if lte IE 9]>
    <p class="browserupgrade">You are using an <strong>outdated</strong> browser. Please <a href="https://browsehappy.com/">upgrade your browser</a> to improve your experience and security.</p>
  <![endif]-->
  <header class="page-header js-page-header">
    <a class="page-header-logo-container" href="https://tech-in-japan.github.io/index.html"></a>
    <div class="page-header-text">Clever Geek Handbook</div>
  </header>
  <section class="page js-page"><h1>Interview with Gary Hudson about the new anti-aging biotechnology</h1><div class="post__text post__text-html js-mediator-article"><img src="https://habrastorage.org/webt/ak/dt/2d/akdt2d910rsrzr8rstetg0cg7_a.jpeg">
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      For the last couple of years, we have seen rapid progress in <a href="https://encrypted.google.com/search%3Fq%3Dsite%253Afightaging.org%2Bsenescent%2520cell%2520clearance">various areas</a> in the <a href="https://www.fightaging.org/archives/2014/07/aiming-to-remove-the-senescent-cell-contribution-to-aging-and-age-related-disease.php">fight against sensate cells</a> .  Recently, <a href="http://unitybiotechnology.com/">UNITY Biotechnology</a> made a <a href="https://www.fightaging.org/archives/2016/02/25-median-life-extension-in-mice-via-senescent-cell-clearance-unity-biotechnology-founded-to-develop-therapies.php">loud statement</a> , and the extension of life by removing senescent cells was demonstrated in mice.  This is a great time for <a href="https://www.fightaging.org/archives/2004/11/strategies-for-engineered-negligible-senescence.php">SENS, Strategies for Engineered Negligible Senescence</a> , because one of the important technologies for rejuvenating the body, which the organization has been promoting and supporting for more than a decade, is now actively moving in the direction of clinical trials.  This allows attracting previously inaccessible venture financing and raises public awareness about the possibility of treating aging. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    <a name="habracut"></a>
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      Today's article is devoted to a new company that cleans the body of senescent cells - <a href="http://oisinbio.com/">Oisin Biotechnologies</a> , founded and funded by Harry Hudson and Matthew Scholz.  Oisin researchers have perhaps the best available approach to removing senescent cells and, I think, have approached its implementation in humans closer than UNITY.  Early prototypes of Oisin's work were known to representatives of the <a href="http://sens.org/">SENS Research Foundation</a> shortly after they began work ‚Äî in a small community everyone is aware of everything, but initial funding in 2014, first from the <a href="https://www.mfoundation.org/">Methuselah Foundation</a> , and a few months later from the SENS Research Foundation, was provided by the efforts of the <a href="https://en.wikipedia.org/wiki/David_Gobel">David Gobel</a> of the Methuselah Foundation  This funding made it possible to successfully test the principle approach in mice, and a new round of investment was held the year before last to begin a new phase of clinical trials.  I am pleased to announce that Fight Aging!  He participated in this round, providing little help in an important research project.  Let me now turn to Harry Hudson of Oisin Biotechnologies, who will explain what approaches they use to develop rejuvenation technologies. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    <h2>  Interview </h2>
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Risen</b> : What is Oisin Biotechnologies, under what conditions did you meet and decide to dedicate your next startup to this? 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Hudson</b> : Oisin was founded by two people, Matthew Scholz, who proposed the basic scientific approach of our first technology and me, together with the Methuselah Foundation and later the SENS Research Foundation, who provided funding as business angels.  I act as CEO while the company is at the initial stage. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      Matt and I met a few years ago at a life extension meeting - the <a href="http://healthextension.co/">Bay Area Health Extension Salon</a> at the evening seminars (organized by <a href="https://en.wikipedia.org/wiki/Joe_Betts-LaCroix">Joe Betts-LaCrox</a> from <a href="https://www.mousera.com/">Mousera</a> ).  It is noteworthy that my friend <a href="https://www.buckinstitute.org/campisiLab">Judy Campisi</a> from the <a href="https://www.buckinstitute.org/">Buck Institute</a> was the main speaker that evening.  Matthew was the first speaker to introduce his then new company in <a href="http://immusoft.com/">Immusoft</a> gene therapy.  Judy spoke about the interesting work that was <a href="https://www.fightaging.org/archives/2011/11/a-demonstration-of-the-merits-of-apoptosens.php">published by Mayo Clinic</a> and showed a significant positive effect on the removal of senescent cells in <a href="https://en.wikipedia.org/wiki/Transgenesis">transgenic</a> mice.  Coincidentally, the continuation of this study was <a href="https://www.fightaging.org/archives/2016/02/25-median-life-extension-in-mice-via-senescent-cell-clearance-unity-biotechnology-founded-to-develop-therapies.php">published in the journal Nature</a> and demonstrated a significant extension of life as a result of the removal of senescent cells in mice with normal aging. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      After discussion, Matthew and I speculated on possible ways to destroy senescent cells that could be used on humans.  (By this time, Matthew had been researching <a href="https://en.wikipedia.org/wiki/Viral_vector">gene therapy vectors</a> for a long time and had worked with the non-viral cell <a href="https://en.wikipedia.org/wiki/Suicide_gene">self-destruction gene</a> developed in Baylor and already used in humans).  Matthew said that, in his opinion, we could use a certain <a href="https://en.wikipedia.org/wiki/Vectors_in_gene_therapy">liposomal vector</a> , which he discovered earlier, in combination with the apoptosis gene to destroy senescent cells in humans.  He said that he was too busy and absorbed in working at Immusoft to start another project, and since this technology was too different from Immusoft technology, working on it would be an undesirable distraction for him.  But the more we talked about it, the more we liked this idea.  Finally, I just said, ‚ÄúThis needs to be done.  If you provide a description of the technology, I will finance everything myself.  I will be the CEO and raise the missing funding in order to check if the method works. ‚Äù  So we issued a license for the liposome vector, applied for a patent and created the first prototype. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    <img src="https://habrastorage.org/webt/u-/mj/j3/u-mjj3xoqahpjxphl9qdwuv3_by.jpeg">
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <i>Kidneys, inguinal fat and lungs</i> 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Risen</b> : You cleanse the body of senescent cells;  what approach do you use and how far have you come? 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Hudson</b> : Our approach is quite different from most attempts to destroy senescent cells.  Our potential therapy includes two components.  First, it is a nucleotide sequence that includes an activator present in the cells that we want to destroy, and a self-destruct gene that causes apoptosis.  This nucleotide sequence can be as simple as that mentioned in <a href="http://dx.doi.org/10.1038/nature10600">Baker's work</a> and destroys cells with the expression <a href="https://en.wikipedia.org/wiki/P16">of p16 protein</a> , or more complex, for example with the inclusion of logic that ensures the selectivity of its work.  The second component is a unique liposomal vector capable of delivering our nucleotide sequence to almost any cell in the body.  This vector is unique due to a combination of efficacy and supposedly high safety even in large doses. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      There is not an obvious but significant difference between our approach and others.  Cell recognition is carried out at the expense of the <a href="https://en.wikipedia.org/wiki/Nucleic_acid_sequence">nucleotide sequence</a> , and not of the vector.  Liposomal vector does not have any preference for senescent cells.  It delivers the nucleotide sequence in both healthy and senescent cells.  Recognition is not at the expense of markers on the surface of cells or other external signs.  As Matthew likes to say, ‚Äúwe destroy cells based on what they have in mind, not on the surface.‚Äù  So, if the activator of our nucleotide sequence (for example, the p16 protein gene) is active in a cell during therapy, the next part of the nucleotide sequence, the self-destruct gene, will be transcribed and cause <a href="https://ru.wikipedia.org/wiki/%25D0%2590%25D0%25BF%25D0%25BE%25D0%25BF%25D1%2582%25D0%25BE%25D0%25B7">apoptosis</a> .  However, if the p16 gene is not activated in a particular cell, nothing will happen, and soon the nucleotide sequence delivered by us will be split by the body.  This provides our therapy with high selectivity and, importantly, the temporary nature of the effect.  Since we do not use the virus to deliver the nucleotide sequence, and our liposomal sequence is not <a href="https://ru.wikipedia.org/wiki/%25D0%2598%25D0%25BC%25D0%25BC%25D1%2583%25D0%25BD%25D0%25BE%25D0%25B3%25D0%25B5%25D0%25BD%25D0%25BD%25D0%25BE%25D1%2581%25D1%2582%25D1%258C">immunogenic</a> , we hope that it can be used repeatedly in one patient. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      So far, we have demonstrated that our vector and nucleotide sequence can effectively and selectively destroy senescent cells in cell culture, and we can target it to insensitive cells <a href="https://en.wikipedia.org/wiki/In_vivo"><i>in vivo</i></a> in mice that received <a href="https://en.wikipedia.org/wiki/Chemotherapy">chemotherapy</a> .  The next step is to demonstrate that we can recognize senescent cells in the same way as in the Mayo Clinic study, but in the translated model - without using the <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468323">INK ‚Äì ATTAC</a> transgenic mice.  After all, humans are not transgenic mice.  With all the achievements of their work, it is purely academic interest;  the medicine applied by them on mice will not help people much.  We hope to receive the first data in the course of the next research this year. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Risen</b> : How is your approach different from the UNITY Biotechnology approach? 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Hudson</b> : I have no direct data regarding the activities in UNITY;  you and I probably read the same articles about their work.  They seem to be concentrating on the development of <a href="https://ru.wikipedia.org/wiki/%25D0%259C%25D0%25B0%25D0%25BB%25D1%258B%25D0%25B5_%25D0%25BC%25D0%25BE%25D0%25BB%25D0%25B5%25D0%25BA%25D1%2583%25D0%25BB%25D1%258B">small molecules</a> .  As I said earlier, we use the technology of gene therapy for temporary exposure.  In other words, we effectively destroy senescent cells using a gene program that we load into our liposomal vector. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      The advantage of our approach compared to using small molecules is that, if necessary, we can very quickly reconfigure our treatment method to destroy a specific type of cell in certain circumstances, or adapt it to ignore certain types of cells - and all just by changing the nucleotide sequence that we deliver.  We have a platform for selective destruction of cells based on very specific and easily changeable genetic criteria.  A medicine based on small molecules does not have this flexibility. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Risen</b> : You just had a round of investment, what are your plans for next year? 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Hudson</b> : As I already mentioned, all the elements of our approach work well, so it‚Äôs time to put all the pieces together and do the work necessary to turn a promising technology into a medicine that changes people's fates.  We hope to conduct several in vivo studies in the near future to assess the effect of therapy on aging due to various reasons.  If funds and time allow, we will also try to determine the optimal doses, the number of courses of administration needed to drastically reduce the number of senescent cells in the body, and so on.  We would also like to conduct a large-scale study of life expectancy in mice and, possibly, other animals.  We will seek cooperation with pharmaceutical companies that focus on specific diseases recognized by the FDA, such as <a href="https://ru.wikipedia.org/wiki/%25D0%25A5%25D1%2580%25D0%25BE%25D0%25BD%25D0%25B8%25D1%2587%25D0%25B5%25D1%2581%25D0%25BA%25D0%25B0%25D1%258F_%25D0%25BE%25D0%25B1%25D1%2581%25D1%2582%25D1%2580%25D1%2583%25D0%25BA%25D1%2582%25D0%25B8%25D0%25B2%25D0%25BD%25D0%25B0%25D1%258F_%25D0%25B1%25D0%25BE%25D0%25BB%25D0%25B5%25D0%25B7%25D0%25BD%25D1%258C_%25D0%25BB%25D1%2591%25D0%25B3%25D0%25BA%25D0%25B8%25D1%2585">COPD</a> , <a href="https://ru.wikipedia.org/wiki/%25D0%2594%25D0%25BE%25D0%25B1%25D1%2580%25D0%25BE%25D0%25BA%25D0%25B0%25D1%2587%25D0%25B5%25D1%2581%25D1%2582%25D0%25B2%25D0%25B5%25D0%25BD%25D0%25BD%25D0%25B0%25D1%258F_%25D0%25B3%25D0%25B8%25D0%25BF%25D0%25B5%25D1%2580%25D0%25BF%25D0%25BB%25D0%25B0%25D0%25B7%25D0%25B8%25D1%258F_%25D0%25BF%25D1%2580%25D0%25B5%25D0%25B4%25D1%2581%25D1%2582%25D0%25B0%25D1%2582%25D0%25B5%25D0%25BB%25D1%258C%25D0%25BD%25D0%25BE%25D0%25B9_%25D0%25B6%25D0%25B5%25D0%25BB%25D0%25B5%25D0%25B7%25D1%258B">BPH,</a> and others. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Risen</b> : What do you think about the global SENS program and the goal of victory over aging? 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Hudson</b> : This topic interests me since adolescence, when we really flew to the moon (not in the sense of Google projects).  When they asked me what I wanted to do in life, I usually and only half jokingly said ‚Äúfly to the stars and live forever‚Äù - borrowing this approach from science fiction writer <a href="https://en.wikipedia.org/wiki/James_Blish">James Blish</a> .  But I found that in 1969 there was no hope for progress in the fight against aging, so I turned my attention to space and became one of the first entrepreneurs in this field.  After 45 years in it, I am ready to devote time to finding an engineering solution to the problem of aging. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      I was the first major contributor to the SENS project.  I participated in the financing of the SENS and <a href="https://en.wikipedia.org/wiki/Methuselah_Foundation">Methuselah Mouse Prize</a> conferences.  I believe that the main approach of SENS to treating aging as an engineering problem ‚Äî repairing, replacing, restoring functions ‚Äî will lead to an increase in the period of healthy life and bring us closer to the ‚Äú <a href="https://en.wikipedia.org/wiki/Longevity_escape_velocity">second space</a> ‚Äù. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Risen</b> : How do you think SENS technology should be brought to clinical trials? 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Hudson</b> : This is a tough question.  Personally, I am not particularly interested in the usual pharmaceutical way to clinical trials.  This does not mean that we (or rather, our partners from the pharmaceutical industry) will not go this way, but its cost must be assessed taking into account the need to attract public attention to these technologies as soon as possible.  Therefore it is necessary to consider alternative ways.  One of the areas that depends little on the traditional path is veterinary medicine and animal treatment.  Development of our new strategy is an important part of my short-term plans, another important area is the next stage of attracting investments in financing the initial stage of the company's development, which took place in 2016. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Risen</b> : If everything works fine and all project participants get rich, what's next? 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      <b>Hudson</b> : In fact, my entire share in Oisin will go to my non-profit organization (which will be announced soon) and will focus on promoting the latest technologies in <a href="https://en.wikipedia.org/wiki/Translational_medicine">translational medicine</a> .  But, although I hope to make a profit on behalf of our investors, my goal in setting up a company was to promote real anti-aging therapies.  If we succeed, we have good chances to earn.  But money is important for me only because it will allow us to move faster to the next problem of aging, and this is what we will do. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    <h2>  Conclusion </h2>
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      If Oisin is a successful company, its success will lead to additional funding from the Methuselah Foundation and the SENS Research Foundation, as well as individuals who already provide tremendous support to the science of life extension.  People who, like myself, understand that the <a href="https://www.fightaging.org/archives/2010/10/the-rational-use-for-excess-money-is-longevity-science">only rational idea was to spend the surplus funds</a> to finance technologies of radical life extension.  What is the meaning of money for the sick and the dead?  <a href="https://www.fightaging.org/archives/2008/02/what-is-wealth">The real value of money</a> nowadays is the ability to spend it on creating technology to defeat aging and disease.  If more people understood this, we would have achieved much more. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    <h2>  Comments by Michael Rae </h2>
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      I am very enthusiastic about the veterinary route of Oisin, than I thought (and think) about testing senoliths <i>per se</i> as part of the Robust Dog Rejuvenation (radical rejuvenation of dogs). 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      First, and most importantly, the state of science is now much better: we used to have interesting, but still limited results for a single senolithic protocol, and now we have a lot of research with several results (including longevity) using different models of aging and different procedures (INK-ATTAC, 3MMR-p16, dasatinib / quercetin, Navitoclax) conducted in more or less normal mice.  Oisin has already done some preliminary work on mice and plans to conduct tests for life expectancy.  This is a very strong scientific base, tested on mice, and it will allow to work on other organisms. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      Secondly, Oisin technology is much closer to true anti-aging biotechnology for removing senescent cells: it directly targets cells based on their aging markers (rather than interfering with metabolism), and has a cleaner (in principle) implementation mechanism (avoiding interference with metabolic pathways relied on by other cells). 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      Thus, it is much more realistic to translate it into a real rejuvenating therapy for people or even dogs than dasatinib / quercetin, - a perspective that I look at with great enthusiasm. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      In principle, this can be a real rejuvenating biotechnology of a person, especially if it is more specific for senescent cells, or several different targeting options can be developed.  The veterinary route is <b>(a)</b> scientifically valuable in and of itself, <b>(b)</b> will cause an intense public response and lead to the acceptance of the reality of intervening in aging, and <b>(c)</b> is a potential strategy that allows for a faster transition to use on a person. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      There are still a lot of problems in RDR: RMR (radical rejuvenation of mice) <i>per se</i> is still the main standard, and if we had a complete panel of rejuvenating biotechnologies needed for its implementation, <b>(a)</b> it would be much preferable to use the technology, in principle similar to Oisin than small molecules, and <b>(b) the</b> mouse remains the best organism for the test.  It takes two years to take an older mouse and double the remaining lifespan;  The equivalent of a dog is about eight years old. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      But I completely agree on the main thing - the day when people first see their dogs (and their friends' dogs) living much longer and healthier (and possibly obviously rejuvenated) after receiving anti-aging procedures will be a turning point in the enthusiasm and recognition of aging as treatable. fatal disease.  The prospect that worries me a lot and should worry us all. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      Translation done Pattern, SENS Volunteers group </div>
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
    
<section class="more-articles-navigation-panel js-more-articles-navigation-panel">
<h4>More articles:</h4>
<nav class="list-of-articles-container js-list-of-articles-container"><ul class="list-of-pages js-list-of-pages">
<li><a href="../409469/index.html">Thinkpad 600: clean DOS in 2018</a></li>
<li><a href="../409471/index.html">Some remarks on gathering requirements for software development.</a></li>
<li><a href="../409473/index.html">The capacity of the human brain for visual images is seriously limited.</a></li>
<li><a href="../409475/index.html">The first trial for repost in Telegram</a></li>
<li><a href="../409479/index.html">Trends from the ‚ÄúHi-Fi World‚Äù at 2018th: Sound podcast</a></li>
<li><a href="../409483/index.html">Early 2000s Ultrabook - Fujitsu LifeBook P-1032 Review</a></li>
<li><a href="../409485/index.html">Inside Alzheimer's</a></li>
<li><a href="../409487/index.html">Rogozin - not the first: an interview with the developer of liquid breathing systems Andrey Filippenko</a></li>
<li><a href="../409491/index.html">Review of AMD Ryzen Threadripper 1950x and 1920x: CPU on steroids</a></li>
<li><a href="../409493/index.html">New Sony: Xperia XA2 Ultra, Xperia XA2 and Xperia L2</a></li>
</ul></nav>
</section><br />
<a href="../../allArticles.html"><strong>All Articles</strong></a>
<script src="../../js/main.js"></script>

<!-- Yandex.Metrika counter -->
<script type="text/javascript" >
  (function (d, w, c) {
      (w[c] = w[c] || []).push(function() {
          try {
              w.yaCounter70218013 = new Ya.Metrika({
                  id:70218013,
                  clickmap:true,
                  trackLinks:true,
                  accurateTrackBounce:true,
                  webvisor:true
              });
          } catch(e) { }
      });

      var n = d.getElementsByTagName("script")[0],
          s = d.createElement("script"),
          f = function () { n.parentNode.insertBefore(s, n); };
      s.type = "text/javascript";
      s.async = true;
      s.src = "https://mc.yandex.ru/metrika/watch.js";

      if (w.opera == "[object Opera]") {
          d.addEventListener("DOMContentLoaded", f, false);
      } else { f(); }
  })(document, window, "yandex_metrika_callbacks");
</script>
<noscript><div><img src="https://mc.yandex.ru/watch/70218013" style="position:absolute; left:-9999px;" alt="" /></div></noscript>

<!-- Google Analytics -->
  <script>
    window.ga = function () { ga.q.push(arguments) }; ga.q = []; ga.l = +new Date;
    ga('create', 'G-FEDBM7F51Q', 'auto'); ga('send', 'pageview')
  </script>
  <script src="https://www.google-analytics.com/analytics.js" async defer></script>

</section>

<footer class="page-footer">
  <div class="page-footer-legal-info-container page-footer-element">
    <p>
      Clever Geek | <span class="page-footer-legal-info-year js-page-footer-legal-info-year">2020</span>
    </p>
  </div>
  <div class="page-footer-counters-container page-footer-element">
    <div class="company-info js-company-info" itemscope="" itemtype="http://schema.org/Organization">
      <span itemprop="name">Western Town Media (WTM)</span>
      <div itemprop="address" itemscope="" itemtype="http://schema.org/PostalAddress">
        <span itemprop="streetAddress">1968 Stoney Lonesome Road</span>
        <br>
        <span itemprop="postalCode">PA 18640</span>
        <span itemprop="addressLocality">Pittston, USA</span>
      </div>
      <span itemprop="telephone">570-362-1316</span>
    </div>
    <script type="application/ld+json">
      {
        "@context": "http://schema.org",
        "@type": "Organization",
        "address": {
          "@type": "PostalAddress",
          "addressLocality": "Pittston, USA",
          "postalCode": "PA 18640",
          "streetAddress": "1968 Stoney Lonesome Road"
        },
        "name": "Western Town Media (WTM)",
        "telephone": "570-362-1316"
      }
    </script>
  </div>
</footer>
  
</body>

</html>